Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)

NCT06670651 is registered in ClinicalTrials.gov with LinkBio Corp. as lead sponsor.

NCT NCT06670651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06670651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
Lead sponsor
LinkBio Corp.
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 21, 2025
Completion date
December 31, 2031
Enrollment
600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fracture, osteoarthritis (oa) of the knee, rheumatoid arthritis